Melatonin reduces tachycardia in postural tachycardia syndrome: A randomized, crossover trial

Cardiovascular Therapeutics

Volumn 32, Issue 3, 2014, Pages 105-112

  Green, Elizabeth A ^a   Black, Bonnie K ^a   Biaggioni, Italo ^a,b   Paranjape, Sachin Y ^a   Bagai, Kanika ^a   Shibao, Cyndya ^a   Okoye, Mirian C ^a   Dupont, William D ^a   Robertson, David ^a,b   Raj, Satish R ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomic nervous system; Drugs; Melatonin; Orthostatic intolerance; Sympathetic nervous system; Tachycardia

Indexed keywords

MELATONIN; PLACEBO; ANTIARRHYTHMIC AGENT; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NORADRENALIN BLOOD LEVEL; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SITTING; STANDING; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT OUTCOME; ADRENERGIC SYSTEM; BLOOD; BLOOD PRESSURE; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TIME; UNITED STATES; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; MALE; MELATONIN; NOREPINEPHRINE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; SYMPATHETIC NERVOUS SYSTEM; TENNESSEE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899108294     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12067     Document Type: Article

References (40)

1. Raj SR. Postural tachycardia syndrome (POTS). Circulation 2013;127:2336-2342.
2. Bagai K, Song Y, Ling JF, et al. Sleep disturbances and diminished quality of life in postural tachycardia syndrome. J Clin Sleep Med 2011;7:204-210.
3. Garland EM, Raj SR, Black BK, et al. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 2007;69:790-798.
4. Masana MI, Doolen S, Ersahin C, et al. MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 2002;302:1295-1302.
5. Jin X, von GC, Pieschl RL, et al. Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003;23:1054-1060.
6. Zhdanova IV, Wurtman RJ, Morabito C, et al. Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep 1996;19:423-431.
7. Serfaty M, Kennell-Webb S, Warner J, et al. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 2002;17:1120-1127.
8. Nishiyama K, Yasue H, Moriyama Y, et al. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J 2001;141:E9.
9. Cagnacci A, Arangino S, Angiolucci M, et al. Influences of melatonin administration on the circulation of women. Am J Physiol 1998;274:R335-R338.
10. Ray CA. Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans. J Physiol 2003;551:1043-1048.
11. Harris AS, Burgess HJ, Dawson D. The effects of day-time exogenous melatonin administration on cardiac autonomic activity. J Pineal Res 2001;31:199-205.
12. Arangino S, Cagnacci A, Angiolucci M, et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999;83:1417-1419.
13. Cook JS, Sauder CL, Ray CA. Melatonin differentially affects vascular blood flow in humans. Am J Physiol Heart Circ Physiol 2011;300:H670-H674.
14. Kitajima T, Kanbayashi T, Saitoh Y, et al. The effects of oral melatonin on the autonomic function in healthy subjects. Psychiatry Clin Neurosci 2001;55:299-300.
15. Raj SR, Biaggioni I, Yamhure PC, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005;111:1574-1582.
16. Monarch Pharmaceuticals I. Florinef acetate - fludrocortisone acetate tablet product label. Daily Med NIH Gov 2011. http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=71912 (accessed 7 July 2012).
17. Raj SR, Black BK, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: Less is more. Circulation 2009;120:725-734.
18. Coffin ST, Black BK, Biaggioni I, et al. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm 2012;9:1484-1490.
19. DeMuro RL, Nafziger AN, Blask DE, et al. The absolute bioavailability of oral melatonin. J Clin Pharmacol 2000;40:781-784.
20. Diggle P, Heagerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford: Oxford University Press, 2002.
21. Evans BK, Mason R, Wilson VG. Evidence for direct vasoconstrictor activity of melatonin in "pressurized" segments of isolated caudal artery from juvenile rats. Naunyn Schmiedebergs Arch Pharmacol 1992;346:362-365.
22. Satake N, Oe H, Shibata S. Vasorelaxing action of melatonin in rat isolated aorta; possible endothelium dependent relaxation. Gen Pharmacol 1991;22:1127-1133.
23. Xia CM, Shao CH, Xin L, et al. Effects of melatonin on blood pressure in stress-induced hypertension in rats. Clin Exp Pharmacol Physiol 2008;35:1258-1264.
24. Paulis L, Simko F. Blood pressure modulation and cardiovascular protection by melatonin: Potential mechanisms behind. Physiol Res 2007;56:671-684.
25. Ianas O, Olinescu R, Badescu I. Melatonin involvement in oxidative processes. Endocrinologie 1991;29:147-153.
26. Fares A. Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients. J Cardiovasc Dis Res 2011;2:153-155.
27. Klein DC, Weller JL. Rapid light-induced decrease in pineal serotonin N-acetyltransferase activity. Science 1972;177:532-533.
28. Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997;19:91-102.
29. van den Top M, Buijs RM, Ruijter JM, et al. Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm. Neuroscience 2001;107:99-108.
30. Kalsbeek A, Garidou ML, Palm IF, et al. Melatonin sees the light: Blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin. Eur J Neurosci 2000;12:3146-3154.
31. Coote JH, Yang Z, Pyner S, et al. Control of sympathetic outflows by the hypothalamic paraventricular nucleus. Clin Exp Pharmacol Physiol 1998;25:461-463.
32. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 2000;100:549-556.
33. Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000;342:541-549.
34. Sousa A, Lebreiro A, Freitas J, et al. Long-term follow-up of patients with postural tachycardia syndrome. Clin Auton Res 2012;22:151-153.
35. Brismar K, Mogensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand 1987;221:155-158.
36. Gleiter CH, Deckert J. Adverse CNS-effects of beta-adrenoceptor blockers. Pharmacopsychiatry 1996;29:201-211.
37. Guerrero HY, Gauer F, Pevet P, et al. Daily and circadian expression patterns of mt1 melatonin receptor mRNA in the rat pars tuberalis. Adv Exp Med Biol 1999;460:175-179.
38. Masson-Pevet M, Gauer F, Schuster C, et al. Photic regulation of mt(1) melatonin receptors and 2-iodomelatonin binding in the rat and Siberian hamster. Biol Signals Recept 2000;9:188-196.
39. Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008;85:335-353.
40. Scheer FA, Van Montfrans GA, van Someren EJ, et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004;43:192-197.